Compare LMAT & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMAT | GRDN |
|---|---|---|
| Founded | 1983 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2006 | 2024 |
| Metric | LMAT | GRDN |
|---|---|---|
| Price | $85.14 | $30.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $101.83 | $33.33 |
| AVG Volume (30 Days) | 141.0K | ★ 255.7K |
| Earning Date | 02-26-2026 | 11-10-2025 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | ★ 27.40 | N/A |
| EPS | ★ 2.32 | 0.28 |
| Revenue | $240,866,000.00 | ★ $1,389,638,000.00 |
| Revenue This Year | $15.17 | $19.50 |
| Revenue Next Year | $9.07 | $0.48 |
| P/E Ratio | ★ $36.30 | $109.45 |
| Revenue Growth | 13.07 | ★ 18.68 |
| 52 Week Low | $71.42 | $17.78 |
| 52 Week High | $105.55 | $37.43 |
| Indicator | LMAT | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 51.90 | 53.91 |
| Support Level | $83.73 | $26.34 |
| Resistance Level | $88.21 | $31.90 |
| Average True Range (ATR) | 2.63 | 1.45 |
| MACD | 0.15 | -0.03 |
| Stochastic Oscillator | 55.82 | 79.00 |
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.